<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="23853">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02796261</url>
  </required_header>
  <id_info>
    <org_study_id>OT-15-001</org_study_id>
    <nct_id>NCT02796261</nct_id>
  </id_info>
  <brief_title>Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients</brief_title>
  <acronym>STELLAR</acronym>
  <official_title>A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine With Lomustine Compared to Lomustine Alone in Patients With AA That Progress/Recur After Irradiation and Adjuvant Temozolomide Chemotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Orbus Therapeutics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Orbus Therapeutics, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the efficacy and safety of eflornithine in
      combination with lomustine, compared to lomustine taken alone, in treating patients whose
      anaplastic astrocytoma has recurred/progressed after radiation and temozolomide
      chemotherapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will consist of 4 study periods of up to 50 months in total, consisting of:

      Screening Period - A maximum screening duration of 4 weeks.

      Treatment Period - Treatment Arm A up to 24 months; Treatment Arm B up to 12 months.

      End of Treatment Visit - A minimum of 4 weeks post last treatment for both arms.

      Follow-Up Period - Up to 24 months.

      A total of approximately 280 patients will be randomized in a 1:1 ratio to receive either
      eflornithine + lomustine or lomustine alone.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall survival</measure>
    <time_frame>4 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Progression-free survival (PFS)</measure>
    <time_frame>4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Objective response rate (ORR)</measure>
    <time_frame>4 years</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Clinical benefit response (CBR) based on magnetic resonance imaging (MRI) criteria</measure>
    <time_frame>4 years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>OS rate at 18 months (OS-18)</measure>
    <time_frame>18 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Relevance of OS, PFS, ORR, and CBR to commonly used molecular/genetic biomarkers obtained from most recent pre-study tumor samples</measure>
    <time_frame>4 years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Pharmacokinetic Analysis - Maximum concentrations (Cmax) of eflornithine in plasma will be determined.</measure>
    <time_frame>1 Month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>PK - Area under the curve (AUC) of eflornithine in plasma will be determined.</measure>
    <time_frame>1 Month</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">280</enrollment>
  <condition>Anaplastic Astrocytoma</condition>
  <condition>Recurrent Anaplastic Astrocytoma</condition>
  <arm_group>
    <arm_group_label>Eflornithine + Lomustine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Eflornithine dosed on a 2 weeks on, 1 week off schedule + Lomustine dosed every 6 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lomustine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lomustine dosed every 6 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Eflornithine</intervention_name>
    <description>Eflornithine 2.8 g/m2 administered orally every 8 hours on a 2 week on, 1 week off schedule</description>
    <arm_group_label>Eflornithine + Lomustine</arm_group_label>
    <other_name>DFMO</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lomustine</intervention_name>
    <description>Lomustine 110 mg/m2 administered orally once every 6 weeks</description>
    <arm_group_label>Eflornithine + Lomustine</arm_group_label>
    <arm_group_label>Lomustine</arm_group_label>
    <other_name>CCNU</other_name>
    <other_name>CeeNU</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients must meet all of the following inclusion criteria to be eligible for
        participation in this study:

          -  Surgical or biopsy-proven diagnosis of WHO grade 3 AA.

          -  Unequivocal evidence of first AA tumor progression or recurrence ≤ 3 months prior to
             randomization based on MRI criteria for tumor progression using enlarging Gd-contrast
             enhancement and/or T2 hypersensitivity (Appendix 4). Patients with non-measurable Gd
             contrast enhancing tumors will only be eligible if there is no necrosis seen on MRI
             and/or histopathological confirmation of AA per standard of care procedures is
             obtained within 4 weeks prior to randomization.

          -  First tumor progression or recurrence following surgical resection or biopsy, if
             resection is not feasible, EBRT and temozolomide chemotherapy.

          -  Completion of EBRT ≥ 6 months prior to randomization.

          -  A patient whose AA tumor has progressed or recurred and has had another surgical
             resection prior to randomization will be eligible if a) pathology review confirms AA,
             b) post-surgical MRI demonstrates measurable tumor on T2/FLAIR, and c) MRI performed
             after surgery is within 4 weeks prior to randomization.

          -  Karnofsky Performance Status (KPS) score of &gt; 70.

        Exclusion Criteria:

        Patients who meet any of the following exclusion criteria are not eligible for study
        participation:

          -  MRI defining progression is consistent with a diagnosis of glioblastoma or radiation
             necrosis.

          -  Patients who are considered to be refractory to EBRT and temozolomide but who have
             not progressed.

          -  Prior systemic therapy for recurrence of AA.

          -  Presence of extracranial or leptomeningeal disease.

          -  Prior lomustine use.

          -  Any other clinical condition or prior therapy that, in the opinion of the
             Investigator, would make the patient unsuitable for the study.

          -  Pregnant or breastfeeding.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marietta Franco, MS</last_name>
    <role>Study Director</role>
    <affiliation>Orbus Therapeutics, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marietta Franco, MS</last_name>
    <phone>6504506634</phone>
    <email>marietta.franco@orbustherapeutics.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kathleen Villamejor, BS</last_name>
    <phone>6506569424</phone>
    <email>kathleen.villamejor@orbustherapeutics.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Burt Nabors, MD</last_name>
      <phone>205-934-1813</phone>
      <email>bnabors@uab.edu</email>
    </contact>
    <contact_backup>
      <last_name>Thiru Pillay</last_name>
      <phone>1 (205) 934-1432</phone>
      <email>tpillay@uabmc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Saint Joseph's Hospital and Medical Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lynn Ashby, MD</last_name>
      <phone>602-406-6262</phone>
      <email>lynn.ashby@dignityhealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Catherine Newitt</last_name>
      <phone>1 (602) 406-2141</phone>
      <email>catherine.newitt@dignityhealth.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Green, MD</last_name>
      <phone>323-783-4200</phone>
      <email>richard.m.green@kp.org</email>
    </contact>
    <contact_backup>
      <last_name>Sandra Baker</last_name>
      <phone>1 (310) 517-3896</phone>
      <email>sandra.t.baker@kp.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of California Los Angeles - Jonsson Comprehensive Cancer Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Timothy Cloughesy, MD</last_name>
      <phone>310-825-5321</phone>
      <email>tcloughesy@mednet.ucla.edu</email>
    </contact>
    <contact_backup>
      <last_name>Emese Filka</last_name>
      <phone>1 (310) 794-3521</phone>
      <email>efilka@mednet.ucla.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of California Irvine Medical Center</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniela Bota, MD</last_name>
      <phone>714-456-7032</phone>
      <email>dbota@uci.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jinah Chung</last_name>
      <phone>1 (714) 456-8442</phone>
      <email>jinahec@uci.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Center</name>
      <address>
        <city>Redwood City</city>
        <state>California</state>
        <zip>94063</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Piia Thomas, MD</last_name>
      <phone>650-299-3690</phone>
      <email>piia.e.thomas@kp.org</email>
    </contact>
    <contact_backup>
      <last_name>Nancy Mendelssohn</last_name>
      <phone>1 (650) 299-4165</phone>
      <email>nancy.d.mendelssohn@kp.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95825</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Enrico Lallana, MD</last_name>
      <phone>916-973-5490</phone>
      <email>enrico.c.lallana@kp.org</email>
    </contact>
    <contact_backup>
      <last_name>Renee Cunanan</last_name>
      <phone>1 (916) 973-4885</phone>
      <email>renee.j.cunanan@kp.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of California San Francisco Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicholas Butowski, MD</last_name>
      <phone>415-353-7500</phone>
      <email>nicholas.butowski@ucsf.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jane Rabbitt</last_name>
      <phone>1 (415) 353-7500</phone>
      <email>jane.rabbitt@ucsf.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>John Wayne Cancer Institute</name>
      <address>
        <city>Santa Monica</city>
        <state>California</state>
        <zip>90404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Santosh Kesari, MD</last_name>
      <phone>858-822-7524</phone>
      <email>kesaris@jwci.org</email>
    </contact>
    <contact_backup>
      <last_name>Annie Heng</last_name>
      <phone>1 (310) 829-8265</phone>
      <email>henga@jwci.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Boca Raton Regional Hospital, Eugene M. &amp; Christine E. Lynn Cancer Institute</name>
      <address>
        <city>Boca Raton</city>
        <state>Florida</state>
        <zip>33486</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sajeel Chowdhary, MD</last_name>
      <phone>561-955-3481</phone>
      <email>schowdhary@brrh.com</email>
    </contact>
    <contact_backup>
      <last_name>Pilar Zuniga</last_name>
      <phone>1 (561) 955-3723</phone>
      <email>pzuniga@brrh.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The University of Florida Health System - UF Health Neurosurgery</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Ghiaseddin, MD</last_name>
      <phone>352-273-9000</phone>
      <email>ashley.ghiaseddin@neurosurgery.ufl.edu</email>
    </contact>
    <contact_backup>
      <last_name>Sarah Andrews</last_name>
      <phone>1 (352) 273-7981</phone>
      <email>sarah.andrews@ufl.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of South Florida (USF) - H. Lee Moffitt Cancer Center and Research Institute</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Forsyth, MD</last_name>
      <phone>813-745-4673</phone>
      <email>peter.forsyth@moffitt.org</email>
    </contact>
    <contact_backup>
      <last_name>Melissa Wicklund</last_name>
      <phone>1 (813) 745-3620</phone>
      <email>melissa.wicklund@moffitt.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Piedmont Physicians Neuro-Oncology</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin Dunbar, MD</last_name>
      <phone>404-605-2050</phone>
      <email>erin.dunbar@piedmont.org</email>
    </contact>
    <contact_backup>
      <last_name>Michelle Humphreys</last_name>
      <phone>1 (404) 425-7943</phone>
      <email>michelle.humphreys@piedmont.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Priya Kumthekar, MD</last_name>
      <phone>312-503-1818</phone>
      <email>pkumthe2@nm.org</email>
    </contact>
    <contact_backup>
      <last_name>Rachel Lukas</last_name>
      <phone>1 (312) 695-1371</phone>
      <email>rachel.lukas@northwestern.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Northwestern Medicine CDH Cancer Center</name>
      <address>
        <city>Warrenville</city>
        <state>Illinois</state>
        <zip>60055</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sean Grimm, MD</last_name>
      <phone>630-352-5450</phone>
      <email>sean.grimm@cadencehealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Claudine Gamester</last_name>
      <phone>1 (630) 315-1918</phone>
      <email>claudine.gamster@cadencehealth.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The University of Iowa</name>
      <address>
        <city>Iowa</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Varun Monga, MD</last_name>
      <phone>319-353-8775</phone>
      <email>marian-andersen@uiowa.edu</email>
    </contact>
    <contact_backup>
      <last_name>Karen Parrott</last_name>
      <phone>1 (319) 353-6347</phone>
      <email>karen-parrott@uiowa.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Kentucky Chandler Medical Center</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Villano, MD</last_name>
      <phone>859-257-3379</phone>
      <email>jlvillano@uky.edu</email>
    </contact>
    <contact_backup>
      <last_name>April Howard</last_name>
      <phone>1 (859) 257-2208</phone>
      <email>april.howard@uky.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Norton Cancer Institute - Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Renato LaRocca, MD</last_name>
      <phone>502-561-8200</phone>
      <email>rvl@kci.us</email>
    </contact>
    <contact_backup>
      <last_name>Lisa Bailey</last_name>
      <phone>1 (502) 629-3449</phone>
      <email>lisa.bailey@nortonhealthcare.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Maine Center for Cancer Medicine and Blood Disorders</name>
      <address>
        <city>Scarborough</city>
        <state>Maine</state>
        <zip>04074</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Devon Evans, MD</last_name>
      <phone>207-396-7600</phone>
      <email>evansd@newecs.org</email>
    </contact>
    <contact_backup>
      <last_name>Charlotte Rice</last_name>
      <phone>1 (207) 396-8557</phone>
      <email>ricec@newecs.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tobias Walbert, MD</last_name>
      <phone>313-916-2723</phone>
      <email>smarl1@hfhs.org</email>
    </contact>
    <contact_backup>
      <last_name>Stephanie Marl</last_name>
      <phone>1 (313) 916-9417</phone>
      <email>smarl1@hfhs.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>HCA Midwest Division</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amandeep Kalra, MD</last_name>
      <phone>816-698-7000</phone>
      <email>amandeep.kalra@hcahealthcare.com</email>
    </contact>
    <contact_backup>
      <last_name>Pamela McCann</last_name>
      <phone>1 (816) 2763890</phone>
      <email>pamela.mccann@hcamidwest.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Dent Neurologic Institute</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laszlo Mechtler, MD</last_name>
      <phone>716-558-5670</phone>
      <email>lmechtler@dentinstitute.com</email>
    </contact>
    <contact_backup>
      <last_name>Rebecca Hogan</last_name>
      <phone>1 (716) 558-5670</phone>
      <email>rhogan@dentinstitute.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center, The Neurological Institute</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teri Kreisl, MD</last_name>
      <phone>212-342-0571</phone>
      <email>tnk2109@columbia.edu</email>
    </contact>
    <contact_backup>
      <last_name>Natalie Busby</last_name>
      <phone>1 (212) 304-5686</phone>
      <email>nb2718@columbia.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Minnesota</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sani Kizilbash, MD</last_name>
      <phone>507-293-0494</phone>
      <email>kizilbash.sani@mayo.edu</email>
    </contact>
    <contact_backup>
      <last_name>Susan Steinmetz</last_name>
      <phone>1 (507) 266-5280</phone>
      <email>steinmetz.susan@mayo.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annick Desjardins, MD</last_name>
      <phone>919-668-2993</phone>
      <email>desja002@mc.duke.edu</email>
    </contact>
    <contact_backup>
      <last_name>Susan Boulton</last_name>
      <phone>1 (919) 668-0896</phone>
      <email>susan.boulton@duke.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Health Sciences</name>
      <address>
        <city>Winston Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roy Strowd, MD</last_name>
      <phone>336-713-6979</phone>
      <email>rstrowd@wakehealth.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jennifer Black</last_name>
      <phone>1 (336) 716-9342</phone>
      <email>jhblack@wakehealth.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The Cleveland Clinic, Richard E. Jacobs Health Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Peereboom, MD</last_name>
      <phone>216-445-6068</phone>
      <email>peerebd@ccf.org</email>
    </contact>
    <contact_backup>
      <last_name>Theresa Naska</last_name>
      <phone>1 (216) 445-1690</phone>
      <email>naskat@ccf.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Penn State Milton S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dawit Aregawi, MD</last_name>
      <phone>717-531-3828</phone>
      <email>daregawi@hmc.psu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Nikita Shah</last_name>
      <phone>1 (717) 531-0003</phone>
      <phone_ext>282645</phone_ext>
      <email>nshah3@hmc.psu.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lyndon Kim, MD</last_name>
      <phone>215-955-7000</phone>
      <email>lyndon.kim@jefferson.edu</email>
    </contact>
    <contact_backup>
      <last_name>Kara Pigott</last_name>
      <phone>1 (215) 503-9110</phone>
      <email>kara.pigott@jefferson.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina, Hollings Cancer Center</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scott Lindhorst, MD</last_name>
      <phone>843-792-2568</phone>
      <email>lindhors@musc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Michele DeCandio</last_name>
      <phone>1 (843) 792-9016</phone>
      <email>decandio@musc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Moots, MD</last_name>
      <email>paul.moots@vanderbilt.edu</email>
    </contact>
    <contact_backup>
      <last_name>Brady Spencer</last_name>
      <phone>1 (615) 936-2889</phone>
      <email>brady.spencer@vanderbilt.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Texas Oncology Austin Brain Tumor Center</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Morris Groves, MD</last_name>
      <phone>512-421-4100</phone>
      <email>morris.groves@usoncology.com</email>
    </contact>
    <contact_backup>
      <last_name>Kristen Brueggemann</last_name>
      <phone>1 (512) 427-9400</phone>
      <email>kristen.brueggemann@usoncology.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Neuro-Oncology Associates</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Fink, MD</last_name>
      <phone>214-820-8690</phone>
      <email>karen.fink@bswhealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Allison Schwaer</last_name>
      <phone>1 (214) 820-6168</phone>
      <email>mary.schwaer@bswhealth.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>MD Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Penas-Prado, MD</last_name>
      <phone>713-745-2164</phone>
      <email>mpenaspr@mdanderson.org</email>
    </contact>
    <contact_backup>
      <last_name>Kathy Hunter</last_name>
      <phone>1 (713) 745-5769</phone>
      <email>kuhunter@mdanderson.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Howard Colman, MD</last_name>
      <phone>801-581-7200</phone>
      <email>howard.colman@hci.utah.edu</email>
    </contact>
    <contact_backup>
      <last_name>Brett Johnson</last_name>
      <phone>1 (801) 587-4429</phone>
      <email>brett.johnson@hci.utah.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Waukesha Memorial Hospital</name>
      <address>
        <city>Waukesha</city>
        <state>Wisconsin</state>
        <zip>53188-5031</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hendrikus Krouwer, MD</last_name>
      <phone>262-928-2570</phone>
      <email>hendrikus.krouwer@phci.org</email>
    </contact>
    <contact_backup>
      <last_name>Chanda Miller</last_name>
      <phone>1 (262) 928-5539</phone>
      <email>chanda.miller@phci.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Universtaetsklinikum Erlangen - Neurologische Klinik</name>
      <address>
        <city>Erlangen</city>
        <state>Bayern</state>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Uhl, MD</last_name>
      <phone>+4991318534640</phone>
      <email>martin.uhl@uk-erlangen.de</email>
    </contact>
    <contact_backup>
      <last_name>Christa Gammel</last_name>
      <phone>+4991318534334</phone>
      <email>christa.menzel@uk-erlangen.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Johnn-Wofgang-Goethe-Universitat Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <state>Hessen</state>
        <zip>60528</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oliver Baehr, MD</last_name>
      <phone>+49069630187711</phone>
      <email>oliver.baehr@med.uni-frankfurt.de</email>
    </contact>
    <contact_backup>
      <last_name>Elvira Mueller</last_name>
      <phone>+4969630187711</phone>
      <email>elvira.mueller@kgu.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Bonn - Zentrum fuer Innere Medizin - Medizinische Klinik und Poliklink III</name>
      <address>
        <city>Bonn</city>
        <state>Nordrhein-Westfalen</state>
        <zip>53105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulrich Herrlinger, MD</last_name>
      <phone>+4902282875736</phone>
      <email>ulrich.herrlinger@ukb.uni-bonn.de</email>
    </contact>
    <contact_backup>
      <last_name>Barbara Scholl</last_name>
      <phone>+4922828719887</phone>
      <email>barbara.scholl@ukb.uni-bonn.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Universtatsklinikum Koln Klinik und Poliklinik fur Neurologie</name>
      <address>
        <city>Köln</city>
        <state>Nordrhein-Westfalen</state>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pantelis Stavrinou, MD</last_name>
      <phone>+00492214784572</phone>
      <email>pantelis.stavrinou@uk-koeln.de</email>
    </contact>
    <contact_backup>
      <last_name>Kay Hoelmer</last_name>
      <phone>+4902214786441</phone>
      <email>kay.hoelmer@uk-koeln.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ruhr-Universitaet Bochum - Knappschaftskrankenhaus Bochum-Langendreer - Neurologische</name>
      <address>
        <city>Bochum</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Uwe Schlegel, MD</last_name>
      <phone>+492342993701</phone>
      <email>uwe.schlegel@kk-bochum.de</email>
    </contact>
    <contact_backup>
      <last_name>Sylvia Rekowski</last_name>
      <phone>+4923429983703</phone>
      <email>sylvia.rekowski@kk-bochum.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Universtaetsklinikum Giessen und Marburg GmbH - Marburg - Neurologische Klinik</name>
      <address>
        <city>Marburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Herwig Strik, MD</last_name>
      <phone>+4964215865179</phone>
      <email>strik@med.uni-marburg.de</email>
    </contact>
    <contact_backup>
      <last_name>Gerda Engel</last_name>
      <phone>+4964215866892</phone>
      <email>engelg@med.uni-marburg.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Oncohematology IRST Cesena</name>
      <address>
        <city>Cesena</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marina Faedi, MD</last_name>
      <phone>+390547352640</phone>
      <email>marina.faedi@irst.emr.it</email>
    </contact>
    <contact_backup>
      <last_name>Monia Dall'Agata</last_name>
      <phone>+390547352975</phone>
      <email>monia.dallagata@irst.emr.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS - Instituto Neurologico Carlo Besta</name>
      <address>
        <city>Milano</city>
        <zip>20133</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gaetano Finocchiaro, MD</last_name>
      <phone>39 02-2394-2454</phone>
      <email>gaetano.finocchiaro@istituto-besta.it</email>
    </contact>
    <contact_backup>
      <last_name>Paola Porrati</last_name>
      <phone>+390223942769</phone>
      <email>paola.porrati@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS - Istituto Neurologico Carlo Besta</name>
      <address>
        <city>Milan</city>
        <zip>20133</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paola Porrati</last_name>
      <phone>+390223942769</phone>
      <email>paola.porrati@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Istituto Oncologico Veneto</name>
      <address>
        <city>Padova</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giuseppe Lombardi, MD</last_name>
      <phone>+390498215910</phone>
      <email>giuseppe.lombardi@ioveneto.it</email>
    </contact>
    <contact_backup>
      <last_name>Miriam Farina</last_name>
      <phone>+390498215908</phone>
      <email>miriam.farina@ioveneto.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Senese - Policlinico S. Maria alle Scotte</name>
      <address>
        <city>Siena</city>
        <zip>53100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michele Maio, MD</last_name>
      <phone>+390577586335</phone>
      <email>mmaiocro@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Giovanni Amato</last_name>
      <phone>+390577586326</phone>
      <email>dataman.immonco@ao-siena.toscana.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Citta della Salute e della Scienza di Torino - Ospedale Molinette</name>
      <address>
        <city>Torino</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Riccardo Soffietti, MD</last_name>
      <phone>+390116334904</phone>
      <email>riccardo.soffietti@unito.it</email>
    </contact>
    <contact_backup>
      <last_name>Cinzia Bertolotti</last_name>
      <phone>+390116334904</phone>
      <email>neuro.oncologia.cbertolotti@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Italy</country>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 10, 2017</lastchanged_date>
  <firstreceived_date>June 3, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anaplastic Astrocytoma</keyword>
  <keyword>Grade 3 Glioma</keyword>
  <keyword>Glioma</keyword>
  <keyword>Eflornithine</keyword>
  <keyword>Brain Cancer</keyword>
  <keyword>Brain Tumor</keyword>
  <keyword>Neuro-oncology</keyword>
  <keyword>Progressive Anaplastic Astrocytoma</keyword>
  <keyword>Recurrent Anaplastic Astrocytoma</keyword>
  <keyword>Progressive Glioma</keyword>
  <keyword>Recurrent Glioma</keyword>
  <keyword>Malignant Glioma</keyword>
  <keyword>Progressive Brain Tumor</keyword>
  <keyword>Recurrent Brain Tumor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Astrocytoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lomustine</mesh_term>
    <mesh_term>Eflornithine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
